Hepatitis Monthly
Official Journal of Research Center for Gastroenterology and Liver Diseases
Crossref
1. Research progress of targeted therapy combined with immunotherapy for hepatocellular carcinoma
- Shuqi Xie
- Mengchao Wang
- Chuanxiu Zeng
- Yan Ou
- Lu Zhao
- Dong Wang
- Liwei Chen
- Fanming Kong
- Dan Yi
2. Abnormal Expression of Golgi Protein 73 in Clinical Values and Their Role in HBV-Related Hepatocellular Carcinoma Diagnosis and Prognosis
- Wenli Sai
- Li Wang
- Wenjie Zheng
- Junling Yang
- Liuhong Pan
- Yin Cai
- Liwei Qiu
- Haijian Zhang
- Wei Wu
- Dengfu Yao
3. Reversal of multidrug resistance of hepatocellular carcinoma cells by metformin through inhibitingNF-κBgene transcription
- Wei Wu
- Jun-Ling Yang
- Yi-Lang Wang
- Han Wang
- Min Yao
- Li Wang
- Juan-Juan Gu
- Yin Cai
- Yun Shi
- Deng-Fu Yao
4. Early monitoring values of oncogenic signalling molecules for hepatocellular carcinoma
- Min Yao
- Rong-Fei Fang
- Qun Xie
- Min Xu
- Wen-Li Sai
- Deng-Fu Yao
5. Oncogenic tuftelin 1 as a potential molecular-targeted for inhibiting hepatocellular carcinoma growth
- Meng-Na Wu
- Wen-Jie Zheng
- Wen-Xin Ye
- Li Wang
- Ying Chen
- Jie Yang
- Deng-Fu Yao
- Min Yao